1g50: Difference between revisions

New page: left|200px<br /> <applet load="1g50" size="450" color="white" frame="true" align="right" spinBox="true" caption="1g50, resolution 2.90Å" /> '''CRYSTAL STRUCTURE O...
 
No edit summary
Line 1: Line 1:
[[Image:1g50.gif|left|200px]]<br />
[[Image:1g50.gif|left|200px]]<br /><applet load="1g50" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1g50" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1g50, resolution 2.90&Aring;" />
caption="1g50, resolution 2.90&Aring;" />
'''CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION'''<br />
'''CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION'''<br />


==Overview==
==Overview==
Several crystal structures of human estrogen receptor alpha ligand-binding, domain (hERalpha LBD) complexed with agonist or antagonist molecules have, previously been solved. The proteins had been modified in cysteine, residues (carboxymethylation) or renatured in urea to circumvent, aggregation and denaturation problems. In this work, high-level protein, expression and purification together with crystallization screening, procedure yielded high amounts of soluble protein without renaturation or, modifications steps. The native protein crystallizes in the space group, P3(2) 21 with three molecules in the asymmetric unit. The overall, structure is very similar to that previously reported for the hERalpha LBD, with cysteine carboxymethylated residues thus validating the modification, approach. The present strategy can be adapted to other cases where the, solubility and the proper folding is a difficulty.
Several crystal structures of human estrogen receptor alpha ligand-binding domain (hERalpha LBD) complexed with agonist or antagonist molecules have previously been solved. The proteins had been modified in cysteine residues (carboxymethylation) or renatured in urea to circumvent aggregation and denaturation problems. In this work, high-level protein expression and purification together with crystallization screening procedure yielded high amounts of soluble protein without renaturation or modifications steps. The native protein crystallizes in the space group P3(2) 21 with three molecules in the asymmetric unit. The overall structure is very similar to that previously reported for the hERalpha LBD with cysteine carboxymethylated residues thus validating the modification approach. The present strategy can be adapted to other cases where the solubility and the proper folding is a difficulty.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1G50 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with EST as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1G50 OCA].  
1G50 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=EST:'>EST</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1G50 OCA].  


==Reference==
==Reference==
Line 22: Line 21:
[[Category: Moras, D.]]
[[Category: Moras, D.]]
[[Category: Ruff, M.]]
[[Category: Ruff, M.]]
[[Category: SPINE, Structural.Proteomics.in.Europe.]]
[[Category: SPINE, Structural Proteomics in Europe.]]
[[Category: EST]]
[[Category: EST]]
[[Category: alpha helices]]
[[Category: alpha helices]]
Line 30: Line 29:
[[Category: structural proteomics in europe]]
[[Category: structural proteomics in europe]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:00:47 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:46:07 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA